THE WHAT? Kirin Holdings Co. is set to acquire Japanese skincare and cosmetics brand Fancl for approximately ¥220 billion (US$1.39 billion).
THE DETAILS The acquisition involves an offer of ¥2,690 per share, representing a 40% premium on Fancl’s closing price on Tuesday before the proposal.
THE WHY? This acquisition follows Kirin’s purchase of Australian vitamins maker Blackmores Ltd. for about ¥170 billion last year, as part of its broader strategy to diversify from its core beer business. Kirin aims to achieve ¥500 billion in annual health-care sales, contributing around 20% of its overall revenue.
Clinical aesthetics products refer to a category of products used in the field of medical aesthetics or cosmetic dermatology. These products are typically designed and formulated to be used under the supervision of healthcare professionals, such as dermatologists, plastic surgeons, or trained aestheticians. They are distinct from over-the-counter cosmetics in that they often contain active ingredients or formulations that require expertise in their application or administration.
Examples of clinical aesthetics products include:
-
Dermal Fillers: Injectable substances used to add volume, smooth wrinkles, and enhance facial contours. Examples include hyaluronic acid fillers like Juvederm and Restylane.
-
Botulinum Toxin (Botox): Injectables that temporarily paralyze facial muscles to reduce the appearance of wrinkles caused by repetitive movements, such as frown lines and crow's feet.
-
Chemical Peels: Solutions applied to the skin to exfoliate and improve its texture. They can treat acne, pigmentation issues, and signs of aging.
-
Laser and Light Therapies: Devices that emit focused light or laser energy to treat various skin conditions, including acne, scars, and signs of aging.
-
Prescription Skincare Products: Formulations containing active ingredients like retinoids (vitamin A derivatives), hydroquinone, or prescription-strength antioxidants to address specific skin concerns under medical supervision.
